Search
Sumario de resultados
TIpos de contenido
Fecha
-
New3P Biopharmaceuticals and Biosergen complete together the manufacture of biomass for the M...
Mucormycosis is a difficult to treat invasive fungal infection with high mortality
-
-
NewSpanish biotechnology sector breaks record figures for six years in a row, according to As...
The AseBio 2021 Report was presented at ICEX in Madrid on Thursday, with the support of Merck, thanks to a journey through 13 of the 17 SDGs on which biotechnology has a direct impact. The document
-
NewORYZON announces a New Financing through a Convertible Bond Program for a Total amount up ...
Funding provided by Nice & Green SA, a Swiss institutional investor
-
NewWith more than 150, medmesafe becomes the online platform with the largest network of labo...
Medmesafe, expands its portfolio of associated companies and, with more than 150, is the online platform with the largest network of laboratories in Spain
-
NewBCN HEALTH publica un estudio evaluando la incidencia hospitalaria y los costes médicos as...
BCN HEALTH has published the study ‘Hospital incidence and costs of congenital hydrocephalus in Spain: a multicenter retrospective study’ in the journal ‘Expert Review of Pharmacoeconomics & Outcomes
-
NewPeregrín establishes a tailor-made MAAVi Lab agreement with Kimitec to lead sustainable a...
Peregrín, has signed a MAAVi Lab or strategic partnership agreement with Kimitec under which both companies will cooperate to develop the most sustainable garlic on the market by 2030
-
NewIUL Instruments at 2022 AACC Annual Scientific Meeting and Clinical Lab Expo in Chicago
IUL will attend the 2022 AACC Annual Scientific Meeting & Clinical Lab Expo in Chicago, one of the most important events in the sector
-
NewIUL celebrates 35 years in business
IUL celebrates its 35th anniversary, increasing its international business trajectory with different product lines and success stories in the microbiological, diagnosis, and veterinary environment
-
NewBTI leads the scientific production of Spanish bio-companies for the seventh consecutive y...
This is the seventh consecutive year that the Vitoria-based biotech company has been ranked number one in scientific production in Spain
-
NewZendal group increases its support for new research projects and doubles the amount of it...
The biotechnological group celebrates this year the 3rd edition of the International Zendal Awards, endowed in this call with 70,000 euros, 130% more than in the 2nd edition
-
NewAmelia Virtual Care welcomes new investors and strengthens its management team
Amelia Virtual Care, previously known as Psious, appoints Afsana Akhter as CEO and Raúl Peris as General Director of Operations
-
NewBioiberica consolidates its ethical corporate governance
This endorses the company's commitment and responsibility to strengthen and consolidate its ethical corporate governance based on the strictest legal and regulatory standards
-
NewNatac successfully acquires INOREAL to expand their saffron natural product portfolio
Natac is dedicated to investigate, develop and sustainably manufacture plant extracts and compounds of natural origin. We successfully acquired INOREAL significantly expanding Natac’s presence in the
-
-
NewYsios Capital appoints Wen Wen Cheng as Head of Legal
Wen Wen Cheng joins Ysios Capital as Head of Legal after 10 years at Cuatrecasas, Barcelona
-
New“The AseBio Report reflects two decades of growth in the Spanish biotech sector”
The latest edition will be presented on 7 July in Madrid. Raquel Álvarez is head of Intelligence and Statistics at AseBio and has been compiling this benchmark document for the industry for 15 years
-
NewDR Healtchare lanza la campaña “Me Again” para dar a conocer el déficit de DAO 9 junio, 20...
DR Healthcare se prepara para el lanzamiento de su nueva campaña de comunicación sobre el déficit de DAO
-
EventAgeingFIT 2023
-
NewSanofi-GSK next-generation COVID-19 booster delivers strong immune response against varian...
Next-generation booster vaccine candidate delivers immune boost in adults primed with mRNA vaccines; with a stronger immune response compared to Pfizer-BioNTech’s Comirnaty booster vaccine
-
NewBIOLAN HEALTH takes over the presidency of the BASQUE HEALTH CLUSTER
At the Basque Health Cluster Assembly held on 9 June, the renewal of the Board of Directors was approved, whose president will now be Asier Albizu, CEO of Biolan Health, replacing Mikel Álvarez